Alcon (XSWX:ALC) EBIT per Share : CHF2.23 (TTM As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Alcon EBIT per Share?

Alcon's EBIT per Share for the three months ended in Sep. 2024 was CHF0.58. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was CHF2.23.

During the past 12 months, the average EBIT per Share Growth Rate of Alcon was 38.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Alcon's EBIT per Share or its related term are showing as below:

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Alcon was -77.70% per year. The lowest was -77.70% per year. And the median was -77.70% per year.

XSWX:ALC's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 6.75
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Alcon's EBIT for the three months ended in Sep. 2024 was CHF289 Mil.

Alcon EBIT per Share Historical Data

The historical data trend for Alcon's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon EBIT per Share Chart

Alcon Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.44

-0.93

1.00

1.13

1.78

Alcon Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.52	0.37	0.68	0.59	0.58

Alcon EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Alcon's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	882.961	/	496.500
=	1.78

Alcon's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	288.895	/	497.700
=	0.58

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.23

Alcon (XSWX:ALC) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Alcon EBIT per Share Related Terms

Thank you for viewing the detailed overview of Alcon's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Alcon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (XSWX:ALC) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

ALC:USA ALCz:UK 0A0D:UK

Address

Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214

Website

https://www.alcon.com

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.